Over the last 180 days, Emmaus Life Sciences, Inc. insiders bought a net $15.0K of stock across 206 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see 201 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
no 13F holders found for this ticker
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $12.5M | $16.7M | $29.6M | $18.4M |
| GROSS PROFIT | $11.6M | $15.5M | $28.3M | $15.8M |
| OPERATING INCOME | $231.0K | $-1.9M | $3.5M | $-6.6M |
| NET INCOME | $-7.5M | $-6.5M | $-3.7M | $-10.6M |
| EPS (DILUTED) | -0.12 | -0.10 | -0.07 | -0.21 |
| OPERATING CASH FLOW | $-11.0K | $-2.3M | $-1.5M | $-5.1M |
| CASH | $2.1M | $1.4M | $2.5M | $2.0M |
| LONG-TERM DEBT | $27.1M | $29.0M | $30.6M | $30.4M |
No password to create and no card required. We store your email address and nothing else.